Literature DB >> 20726460

Audit of treatment of Staphylococcus aureus bacteraemia.

V Wong1, R Wariyar, V Weston, W J Olver, E Youngs, A Hussain, N Perera, A Swann.   

Abstract

Staphylococcus aureus bacteraemia remains a significant cause of morbidity and mortality. National guidelines recommend that a minimum of 14 days of antibiotics should be used to treat uncomplicated bacteraemia. Five hospitals in the East Midlands region conducted a retrospective audit to assess compliance to these guidelines before and after the introduction of extra text to laboratory reports of S. aureus bacteraemia advising clinicians on the minimum length of treatment. Introduction of this extra text resulted in an increase in compliance with the national recommendation from 44% to 60%. This increase in compliance was noted in both methicillin-sensitive S. aureus (45% versus 58%) and methicillin-resistant S. aureus (42% versus 62%) bacteraemia. This audit demonstrated a simple and effective intervention that has improved the treatment of this potentially life-threatening condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726460      PMCID: PMC5873555          DOI: 10.7861/clinmedicine.10-3-266

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  9 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Clin Infect Dis       Date:  2001-04-03       Impact factor: 9.079

2.  Evaluation of clinical guidelines for the management of Staphylococcus aureus bacteraemia.

Authors:  C C Blyth; H Darragh; A Whelan; J P O'Shea; M H Beaman; J S McCarthy
Journal:  Intern Med J       Date:  2002 May-Jun       Impact factor: 2.048

3.  Accuracy and completeness of the documentation of blood culture results.

Authors:  J R Greig
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

4.  Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review.

Authors:  I I Raad; M F Sabbagh
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

5.  The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

Authors:  M P Weinstein; M L Towns; S M Quartey; S Mirrett; L G Reimer; G Parmigiani; L B Reller
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

6.  Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions.

Authors:  S Lautenschlager; C Herzog; W Zimmerli
Journal:  Clin Infect Dis       Date:  1993-04       Impact factor: 9.079

7.  Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

Authors:  Allan G Jensen; Carsten H Wachmann; Frank Espersen; Jens Scheibel; Peter Skinhøj; Niels Frimodt-Møller
Journal:  Arch Intern Med       Date:  2002-01-14

Review 8.  Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom.

Authors:  F Kate Gould; Richard Brindle; Paul R Chadwick; Adam P Fraise; Simon Hill; Dilip Nathwani; Geoff L Ridgway; Michael J Spry; Rod E Warren
Journal:  J Antimicrob Chemother       Date:  2009-03-12       Impact factor: 5.790

9.  Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection.

Authors:  P B Iannini; K Crossley
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

  9 in total
  1 in total

1.  The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation.

Authors:  Guy E Thwaites
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.